Literature DB >> 8589678

The complete sequence of the coding region of the ATM gene reveals similarity to cell cycle regulators in different species.

K Savitsky1, S Sfez, D A Tagle, Y Ziv, A Sartiel, F S Collins, Y Shiloh, G Rotman.   

Abstract

Ataxia-telangiectasia (A-T) is an autosomal recessive disorder involving cerebellar degeneration, immunodeficiency radiation sensitivity, and cancer predisposition. A-T heterozygotes are moderately cancer prone. The A-T gene, designated ATM, was recently identified in our laboratory by positional cloning, and a partial cDNA clone was found to encode a polypeptide with a PI-3 kinase domain. We report here the molecular cloning of a cDNA contig spanning the complete open reading frame of the ATM gene. The predicted protein of 3056 amino acids shows significant sequence similarities to several large proteins in yeast, Drosophila and mammals, all of which share the PI-3 kinase domain. Many of these proteins are involved in the detection of DNA damage and the control of cell cycle progression. Mutations in their genes confer a variety of phenotypes with features similar to those observed in human A-T cells. The complete sequence of the ATM gene product provides useful clues to the function of this protein, and furthers understanding of the pleiotropic nature of the A-T mutations.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8589678     DOI: 10.1093/hmg/4.11.2025

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  115 in total

Review 1.  The pathogenesis of ataxia-telangiectasia. Learning from a Rosetta Stone.

Authors:  R A Gatti; S Becker-Catania; H H Chun; X Sun; M Mitui; C H Lai; N Khanlou; M Babaei; R Cheng; C Clark; Y Huo; N C Udar; R K Iyer
Journal:  Clin Rev Allergy Immunol       Date:  2001-02       Impact factor: 8.667

2.  Purification and DNA binding properties of the ataxia-telangiectasia gene product ATM.

Authors:  G C Smith; R B Cary; N D Lakin; B C Hann; S H Teo; D J Chen; S P Jackson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

3.  ATM protein synthesis patterns in sporadic breast cancer.

Authors:  R Kairouz; R A Clarke; P J Marr; D Watters; M F Lavin; J H Kearsley; C S Lee
Journal:  Mol Pathol       Date:  1999-10

4.  Requirement of ATM in phosphorylation of the human p53 protein at serine 15 following DNA double-strand breaks.

Authors:  K Nakagawa; Y Taya; K Tamai; M Yamaizumi
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

5.  UV irradiation causes the loss of viable mitotic recombinants in Schizosaccharomyces pombe cells lacking the G(2)/M DNA damage checkpoint.

Authors:  Fekret Osman; Irina R Tsaneva; Matthew C Whitby; Claudette L Doe
Journal:  Genetics       Date:  2002-03       Impact factor: 4.562

6.  The yeast TEL1 gene partially substitutes for human ATM in suppressing hyperrecombination, radiation-induced apoptosis and telomere shortening in A-T cells.

Authors:  E Fritz; A A Friedl; R M Zwacka; F Eckardt-Schupp; M S Meyn
Journal:  Mol Biol Cell       Date:  2000-08       Impact factor: 4.138

7.  Isolation of full-length ATM cDNA and correction of the ataxia-telangiectasia cellular phenotype.

Authors:  N Zhang; P Chen; K K Khanna; S Scott; M Gatei; S Kozlov; D Watters; K Spring; T Yen; M F Lavin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

8.  Protein kinase activity of Tel1p and Mec1p, two Saccharomyces cerevisiae proteins related to the human ATM protein kinase.

Authors:  J C Mallory; T D Petes
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

9.  The controlling role of ATM in homologous recombinational repair of DNA damage.

Authors:  C Morrison; E Sonoda; N Takao; A Shinohara; K Yamamoto; S Takeda
Journal:  EMBO J       Date:  2000-02-01       Impact factor: 11.598

10.  Potential protein partners for the N-terminal domain of human topoisomerase I revealed by phage display.

Authors:  Agata M Trzcińska; Agnieszka Girstun; Agnieszka Piekiełko; Barbara Kowalska-Loth; Krzysztof Staroń
Journal:  Mol Biol Rep       Date:  2002-12       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.